ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

Motilal Oswal Nifty MidSmall Healthcare Index Fund

MOTILAL Motilal Oswal Mutual Fund Nov 2024 — Sep 2026 21 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹52.57 CrAt NSE closes, Sep 2026
Companies held3030 with an NSE price
Top 10 holdings58.7%Of the equity shown here
Largest holding11.8%Laurus Labs Limited
12-month turnover4.8%Estimated from 8 monthly disclosures · compare

Days to sell half: 0.1 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

21 priced months, Nov 2024 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

58.7% now, 57.8% in Sep 2025 · highest 62.4%, lowest 57.8%

Companies held

30 now, 30 in Sep 2025 · largest single holding 11.8% of equity

How it trades: no clear lean toward recent winners or losers (score -0.00 over 18 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Sector mix

Share of the equity shown · NSE industry

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. TATA NIFTY MIDSMALL HEALTHCARE INDEX FUNDTata · 30 shared100.0%
  2. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 30 shared48.4%
  3. Mirae Asset Healthcare FundMirae Asset · 17 shared47.6%
  4. Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas · 15 shared44.0%
  5. Nippon India Nifty Pharma ETFNippon India · 14 shared43.1%
  6. ICICI Prudential Nifty Pharma Index FundICICI Prudential · 14 shared43.1%
  7. Bandhan BSE Healthcare Index FundBandhan · 30 shared40.8%
  8. Motilal Oswal BSE Healthcare ETFMotilal Oswal · 30 shared40.8%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 1 Companies added
Complete exits 1 Companies sold out
Increases 29 More shares than last month
Reductions 0 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Laurus Labs Limited Healthcare Mid Cap 11.82% 6.22 Cr 31,389 by Nov 2024 (21 mo+)
Lupin Limited Healthcare Mid Cap 7.56% 3.97 Cr 19,577 by Nov 2024 (21 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 7.08% 3.72 Cr 22,273 by Nov 2024 (21 mo+)
Fortis Healthcare Limited Healthcare Mid Cap 6.15% 3.23 Cr 41,993 by Nov 2024 (21 mo+)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 5.39% 2.83 Cr 12,134 by Nov 2024 (21 mo+)
Alkem Laboratories Limited Healthcare Mid Cap 4.77% 2.51 Cr 4,860 by Nov 2024 (21 mo+)
Mankind Pharma Limited Healthcare Mid Cap 4.35% 2.29 Cr 9,133 by Nov 2024 (21 mo+)
IPCA Laboratories Limited Healthcare Mid Cap 4.10% 2.16 Cr 11,197 by Nov 2024 (21 mo+)
Biocon Limited Healthcare Mid Cap 3.96% 2.08 Cr 56,168 by Nov 2024 (21 mo+)
Gland Pharma Limited Healthcare Small Cap 3.54% 1.86 Cr 6,423 by Nov 2024 (21 mo+)
Sai Life Sciences Limited Healthcare Small Cap 3.23% 1.70 Cr 11,147 Apr 2026 (6 mo)
Krishna Institute of Medical Sciences Limited Healthcare Small Cap 3.05% 1.61 Cr 21,508 by Nov 2024 (21 mo+)
Aster DM Quality Care Limited Healthcare Small Cap 2.86% 1.50 Cr 21,543 by Nov 2024 (21 mo+)
Neuland Laboratories Limited Healthcare Small Cap 2.82% 1.48 Cr 695 Mar 2025 (17 mo)
Wockhardt Limited Healthcare Small Cap 2.68% 1.41 Cr 6,658 Sep 2025 (11 mo)
Acutaas Chemicals Limited Healthcare Small Cap 2.61% 1.37 Cr 4,182 Jul 2026 (3 mo)
Ajanta Pharma Limited Healthcare Small Cap 2.53% 1.33 Cr 3,674 by Nov 2024 (21 mo+)
Dr. Lal Path Labs Ltd. Healthcare Small Cap 2.38% 1.25 Cr 6,288 by Nov 2024 (21 mo+)
Abbott India Limited Healthcare Mid Cap 2.17% 1.14 Cr 420 by Nov 2024 (21 mo+)
Piramal Pharma Limited Healthcare Small Cap 1.97% 1.03 Cr 50,063 by Nov 2024 (21 mo+)
Granules India Limited Healthcare Small Cap 1.91% 1.01 Cr 11,886 by Nov 2024 (21 mo+)
Narayana Hrudayalaya Ltd. Healthcare Mid Cap 1.90% 1.00 Cr 5,568 by Nov 2024 (21 mo+)
Global Health Limited Healthcare Mid Cap 1.85% 0.98 Cr 7,143 by Nov 2024 (21 mo+)
Onesource Specialty Pharma Limited Healthcare Small Cap 1.84% 0.97 Cr 6,344 Sep 2025 (11 mo)
GlaxoSmithKline Pharmaceuticals Limited Healthcare Mid Cap 1.76% 0.92 Cr 3,337 by Nov 2024 (21 mo+)
Anthem Biosciences Limited Healthcare Mid Cap 1.42% 0.75 Cr 8,696 Sep 2026 (1 mo)
Natco Pharma Limited Healthcare Small Cap 1.14% 0.60 Cr 7,241 by Nov 2024 (21 mo+)
Cohance Lifesciences Limited Healthcare Small Cap 1.11% 0.58 Cr 13,112 by Nov 2024 (21 mo+)
Syngene International Limited Healthcare Small Cap 1.06% 0.56 Cr 15,303 by Nov 2024 (21 mo+)
Poly Medicure Limited Healthcare Small Cap 0.98% 0.52 Cr 3,077 by Nov 2024 (21 mo+)

Half of its current holdings have been held for 21 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Anthem Biosciences Limited Sep 2026 ▲ New position +8,696
Piramal Pharma Limited Sep 2026 ▲ Increasing +2,453
Fortis Healthcare Limited Sep 2026 ▲ Increasing +2,104
Krishna Institute of Medical Sciences Limited Sep 2026 ▲ Increasing +1,665
Laurus Labs Limited Sep 2026 ▲ Increasing +1,607
Biocon Limited Sep 2026 ▲ Increasing +1,557
Pfizer Limited Sep 2026 ▼ Complete exit -1,160
Aurobindo Pharma Limited Sep 2026 ▲ Increasing +1,086
Aster DM Quality Care Limited Sep 2026 ▲ Increasing +1,079
Lupin Limited Sep 2026 ▲ Increasing +988
Granules India Limited Sep 2026 ▲ Increasing +778
Syngene International Limited Sep 2026 ▲ Increasing +750
Cohance Lifesciences Limited Sep 2026 ▲ Increasing +658
Glenmark Pharmaceuticals Limited Sep 2026 ▲ Increasing +609
Global Health Limited Sep 2026 ▲ Increasing +588
Sai Life Sciences Limited Sep 2026 ▲ Increasing +586
IPCA Laboratories Limited Sep 2026 ▲ Increasing +564
Mankind Pharma Limited Sep 2026 ▲ Increasing +496
Ajanta Pharma Limited Sep 2026 ▲ Increasing +450
Alkem Laboratories Limited Sep 2026 ▲ Increasing +381
Natco Pharma Limited Sep 2026 ▲ Increasing +364
Wockhardt Limited Sep 2026 ▲ Increasing +337
Onesource Specialty Pharma Limited Sep 2026 ▲ Increasing +325
Gland Pharma Limited Sep 2026 ▲ Increasing +324
Dr. Lal Path Labs Ltd. Sep 2026 ▲ Increasing +323
Narayana Hrudayalaya Ltd. Sep 2026 ▲ Increasing +279
Acutaas Chemicals Limited Sep 2026 ▲ Increasing +212
GlaxoSmithKline Pharmaceuticals Limited Sep 2026 ▲ Increasing +169
Poly Medicure Limited Sep 2026 ▲ Increasing +153
Neuland Laboratories Limited Sep 2026 ▲ Increasing +35
Abbott India Limited Sep 2026 ▲ Increasing +21
Biocon Limited Aug 2026 ▲ Increasing +3,709
Piramal Pharma Limited Aug 2026 ▲ Increasing +3,234
Fortis Healthcare Limited Aug 2026 ▲ Increasing +2,710
Aster DM Quality Care Limited Aug 2026 ▲ Increasing +2,400
Laurus Labs Limited Aug 2026 ▲ Increasing +2,023
Aurobindo Pharma Limited Aug 2026 ▲ Increasing +1,439
Krishna Institute of Medical Sciences Limited Aug 2026 ▲ Increasing +1,347
Lupin Limited Aug 2026 ▲ Increasing +1,263
Syngene International Limited Aug 2026 ▲ Increasing +989
Cohance Lifesciences Limited Aug 2026 ▲ Increasing +846
Glenmark Pharmaceuticals Limited Aug 2026 ▲ Increasing +783
Granules India Limited Aug 2026 ▲ Increasing +754
IPCA Laboratories Limited Aug 2026 ▲ Increasing +723
Sai Life Sciences Limited Aug 2026 ▲ Increasing +717
Mankind Pharma Limited Aug 2026 ▲ Increasing +560
Natco Pharma Limited Aug 2026 ▲ Increasing +467
Global Health Limited Aug 2026 ▲ Increasing +446
Wockhardt Limited Aug 2026 ▲ Increasing +429
Gland Pharma Limited Aug 2026 ▲ Increasing +414
Onesource Specialty Pharma Limited Aug 2026 ▲ Increasing +408
Dr. Lal Path Labs Ltd. Aug 2026 ▲ Increasing +405
Narayana Hrudayalaya Ltd. Aug 2026 ▲ Increasing +359
Alkem Laboratories Limited Aug 2026 ▲ Increasing +304
Acutaas Chemicals Limited Aug 2026 ▲ Increasing +270
Ajanta Pharma Limited Aug 2026 ▲ Increasing +219
GlaxoSmithKline Pharmaceuticals Limited Aug 2026 ▲ Increasing +215
Poly Medicure Limited Aug 2026 ▲ Increasing +199
Pfizer Limited Aug 2026 ▲ Increasing +79
Neuland Laboratories Limited Aug 2026 ▲ Increasing +45
Abbott India Limited Aug 2026 ▲ Increasing +27
Biocon Limited Jul 2026 ▲ Increasing +5,897
J.B. Chemicals & Pharmaceuticals Lt Jul 2026 ▼ Complete exit -5,164
Piramal Pharma Limited Jul 2026 ▲ Increasing +5,141
Fortis Healthcare Limited Jul 2026 ▲ Increasing +4,306
Acutaas Chemicals Limited Jul 2026 ▲ New position +3,700
Laurus Labs Limited Jul 2026 ▲ Increasing +3,216
Aurobindo Pharma Limited Jul 2026 ▲ Increasing +2,287
Krishna Institute of Medical Sciences Limited Jul 2026 ▲ Increasing +2,143
Aster DM Quality Care Limited Jul 2026 ▲ Increasing +2,093
Lupin Limited Jul 2026 ▲ Increasing +2,007
Syngene International Limited Jul 2026 ▲ Increasing +1,571
Cohance Lifesciences Limited Jul 2026 ▲ Increasing +1,344
Glenmark Pharmaceuticals Limited Jul 2026 ▲ Increasing +1,244
Granules India Limited Jul 2026 ▲ Increasing +1,200
IPCA Laboratories Limited Jul 2026 ▲ Increasing +1,148
Sai Life Sciences Limited Jul 2026 ▲ Increasing +1,141
Mankind Pharma Limited Jul 2026 ▲ Increasing +935
Natco Pharma Limited Jul 2026 ▲ Increasing +743
Global Health Limited Jul 2026 ▲ Increasing +707
Wockhardt Limited Jul 2026 ▲ Increasing +683
Gland Pharma Limited Jul 2026 ▲ Increasing +659
Onesource Specialty Pharma Limited Jul 2026 ▲ Increasing +650
Dr. Lal Path Labs Ltd. Jul 2026 ▲ Increasing +644
Narayana Hrudayalaya Ltd. Jul 2026 ▲ Increasing +571
Alkem Laboratories Limited Jul 2026 ▲ Increasing +484
Ajanta Pharma Limited Jul 2026 ▲ Increasing +348
GlaxoSmithKline Pharmaceuticals Limited Jul 2026 ▲ Increasing +342
Poly Medicure Limited Jul 2026 ▲ Increasing +316
Pfizer Limited Jul 2026 ▲ Increasing +125
Neuland Laboratories Limited Jul 2026 ▲ Increasing +71
Abbott India Limited Jul 2026 ▲ Increasing +43
Biocon Limited Jun 2026 ▲ Increasing +3,840
Piramal Pharma Limited Jun 2026 ▲ Increasing +3,495
Fortis Healthcare Limited Jun 2026 ▲ Increasing +2,816
Krishna Institute of Medical Sciences Limited Jun 2026 ▲ Increasing +2,112
Laurus Labs Limited Jun 2026 ▲ Increasing +2,102
Onesource Specialty Pharma Limited Jun 2026 ▲ Increasing +1,782
Aster DM Quality Care Limited Jun 2026 ▲ Increasing +1,372
Aurobindo Pharma Limited Jun 2026 ▲ Increasing +1,341

Changes compare consecutive month-end disclosures for this portfolio only.